These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6133155)
1. Avoidance of perinatal transmission of hepatitis B virus: is passive immunisation always necessary? Rosendahl C; Kochen MM; Kretschmer R; Wegscheider K; Kaiser D Lancet; 1983 May; 1(8334):1127-9. PubMed ID: 6133155 [TBL] [Abstract][Full Text] [Related]
2. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752 [TBL] [Abstract][Full Text] [Related]
3. Perinatal transmission of hepatitis B virus in Thailand. Pongpipat D; Suvatte V; Assateerawatts A Asian Pac J Allergy Immunol; 1985 Dec; 3(2):191-3. PubMed ID: 4074476 [TBL] [Abstract][Full Text] [Related]
4. HBIG immunoprophylaxis of babies born to HBsAg carrier mothers. Zanetti AR; Magliano EM; Tanzi E; Ferroni P; Pirovano G; Pizzocolo G; Pillan N; Zunin C Dev Biol Stand; 1983; 54():383-9. PubMed ID: 6653893 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunoglobulin (HBIG) efficacy in the prevention of perinatal transmission of hepatitis B virus (HBV) infection. Ichida F; Yoshikawa A; Tokunaga A; Takeuchi S Gastroenterol Jpn; 1983 Feb; 18(1):56-9. PubMed ID: 6832550 [TBL] [Abstract][Full Text] [Related]
6. Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report. Zanetti AR; Dentico P; Del Vecchio Blanco C; Sagnelli E; Villa E; Ferroni P; Bergamini F J Med Virol; 1986 Apr; 18(4):327-34. PubMed ID: 2940333 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg. Pongpipat D; Suvatte V; Assateerawatts A Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058 [TBL] [Abstract][Full Text] [Related]
8. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868 [TBL] [Abstract][Full Text] [Related]
9. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus. Nair PV; Weissman JY; Tong MJ; Thursby MW; Paul RH; Henneman CE Gastroenterology; 1984 Aug; 87(2):293-8. PubMed ID: 6376265 [TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831 [TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore. Oon CJ; Tan KL; Goh KT; Wong-Yong L; Viegas O; McCarthy T; Chan SH; Lee HP J Infect; 1986 Nov; 13(3):255-67. PubMed ID: 2947953 [TBL] [Abstract][Full Text] [Related]
14. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive. Gussetti N; Pornaro E; Largajolli G; D'Elia R Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895 [TBL] [Abstract][Full Text] [Related]
15. Reduced doses of hepatitis B immune globulin in the prevention of perinatal transmission of hepatitis B. Ko TM; Lin KH; Ho MM; Hwang MF; Hwang KC; Hsieh FJ; Yaung CL; Chen DS J Med Virol; 1987 Apr; 21(4):301-9. PubMed ID: 3585286 [TBL] [Abstract][Full Text] [Related]
16. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176 [TBL] [Abstract][Full Text] [Related]
17. [Routine screening for serological markers of viral hepatitis B in pregnancy]. Podrouzek P; Mancal P; Kozlová J; Labohá J Cesk Gynekol; 1989 Sep; 54(8):575-80. PubMed ID: 2582501 [TBL] [Abstract][Full Text] [Related]
18. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839 [TBL] [Abstract][Full Text] [Related]
19. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China. Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063 [TBL] [Abstract][Full Text] [Related]